• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙戊酸钠糖浆在各种单位剂量容器中的稳定性。

Stability of valproate sodium syrup in various unit dose containers.

作者信息

Sartnurak S, Christensen J M

出版信息

Am J Hosp Pharm. 1982 Apr;39(4):627-9.

PMID:6805320
Abstract

The stability of valproate sodium syrup repackaged in three types of unit dose containers was studied. Two-millimeter samples of commercial valproate sodium syrup 250 mg/5 ml (of valproic acid) were packaged in polypropylene oral syringes, glass oral syringes, and glass vials (126 of each type). These were stored at 4, 25, or 60 degrees C and assayed for valproic acid concentration using gas chromatography at 0, 5, 10, 20, 30, 90, and 180 days. Polypropylene syringes that were stored for 180 days at 4 and 25 degrees C were rinsed and put in chloroform 50 ml; valproic acid concentration was determined daily for 12 days. Valproate sodium syrup repackaged in glass oral syringes and glass vials retained 95% of valproic acid label claim after storage at 4 and 25 degrees C for 180 days, while valproate sodium syrup repackaged in polypropylene oral syringes did not retain 90% of label claim after storage for 20 days at 4 or 25 degrees C. All samples stored at 60 degrees C had greater loss than those stored at lower temperatures. An average of 86% of the drug lost from the polypropylene syringes was recovered in 12 days during the desorption experiment (range 80-92%). Repackaging valproate sodium syrup in unit dose glass vials or glass syringes resulted in retention of 95% of valproic acid label claim after storage for 180 days at 4 and 25 degrees C. Repackaging of this drug product in polypropylene oral syringes is not recommended.

摘要

研究了重新包装在三种单位剂量容器中的丙戊酸钠糖浆的稳定性。将市售的250mg/5ml(丙戊酸)丙戊酸钠糖浆的2毫米样品分别包装在聚丙烯口服注射器、玻璃口服注射器和玻璃瓶中(每种类型126个)。将这些样品分别储存在4℃、25℃或60℃下,并在0、5、10、20、30、90和180天时使用气相色谱法测定丙戊酸浓度。在4℃和25℃下储存180天的聚丙烯注射器用50ml氯仿冲洗,并在12天内每天测定丙戊酸浓度。重新包装在玻璃口服注射器和玻璃瓶中的丙戊酸钠糖浆在4℃和25℃下储存180天后保留了95%的丙戊酸标签声称量,而重新包装在聚丙烯口服注射器中的丙戊酸钠糖浆在4℃或25℃下储存20天后未保留90%的标签声称量。所有储存在60℃下的样品损失都比储存在较低温度下的样品大。在解吸实验的12天内,从聚丙烯注射器中损失的药物平均有86%被回收(范围为80-92%)。将丙戊酸钠糖浆重新包装在单位剂量玻璃瓶或玻璃注射器中,在4℃和25℃下储存180天后可保留95%的丙戊酸标签声称量。不建议将该药品重新包装在聚丙烯口服注射器中。

相似文献

1
Stability of valproate sodium syrup in various unit dose containers.丙戊酸钠糖浆在各种单位剂量容器中的稳定性。
Am J Hosp Pharm. 1982 Apr;39(4):627-9.
2
Stability of three oral liquid drug products repackaged in unit dose containers.三种重新包装在单位剂量容器中的口服液体制剂的稳定性。
Am J Hosp Pharm. 1983 Apr;40(4):612-5.
3
Stability of dicloxacillin sodium oral suspension stored in polypropylene syringes.储存在聚丙烯注射器中的双氯西林钠口服混悬液的稳定性。
Am J Hosp Pharm. 1987 Jun;44(6):1401-5.
4
Stability of amoxicillin trihydrate-potassium clavulanate in original containers and unit dose oral syringes.阿莫西林三水合物-克拉维酸钾在原装容器和单剂量口服注射器中的稳定性。
Am J Hosp Pharm. 1988 May;45(5):1092-9.
5
Stability of alcohol-free theophylline liquid repackaged in plastic oral syringes.重新包装在塑料口服注射器中的无醇茶碱液体制剂的稳定性。
Am J Hosp Pharm. 1989 May;46(5):980-1.
6
Stability of diazepam injection repackaged in glass unit-dose syringes.玻璃单剂量注射器中重新包装的地西泮注射液的稳定性。
Am J Hosp Pharm. 1982 Oct;39(10):1687-90.
7
Stability of ceftazidime in plastic syringes and glass vials under various storage conditions.头孢他啶在不同储存条件下于塑料注射器和玻璃瓶中的稳定性。
Am J Hosp Pharm. 1992 Nov;49(11):2765-8.
8
Stability of carbamazepine suspension after repackaging into four types of single-dose containers.卡马西平混悬液重新包装至四种单剂量容器后的稳定性。
Am J Hosp Pharm. 1989 May;46(5):982-4.
9
Stability of terbutaline sulfate repackaged in disposable plastic syringes.硫酸特布他林在一次性塑料注射器中重新包装后的稳定性。
Am J Hosp Pharm. 1987 Oct;44(10):2291-3.
10
Stability of cephalexin monohydrate suspension in polypropylene oral syringes.头孢氨苄一水合物混悬液在聚丙烯口服注射器中的稳定性。
Am J Hosp Pharm. 1988 Jun;45(6):1353-6.